RBGPF - What's Going On With Abbott Laboratories Stock On Friday? | Benzinga
An Illinois jury has issued a verdict compelling Reckitt Benckiser Group Plc’s (OTC:RBGLY) (OTC:RBGPF) Mead Johnson to pay $60 million to the mother of a premature infant who tragically succumbed to necrotizing enterocolitis (NEC) after being fed the company’s Enfamil baby formula.
The jury found Mead Johnson negligent for failing to warn of the risks associated with NEC, a disease that mostly affects premature newborns, with a mortality rate ranging from 15% to 40%.
The verdict signifies the opening of a legal floodgate, with hundreds of similar lawsuits pending against Mead Johnson and Abbott Laboratories Inc (NYSE:ABT) regarding ...